Replies to post #75310 on Muscle Pharm Corporation (MSLPQ)

[TheExpertHimself]

Institutional investors will never touch the Musclepharm stock with the current top management and the current board of directors.

Musclepharm got Wynnefield Capital in and Musclepharm screwed them....Brad fooled investors to believe in 2014 profitability, Nasdaq uplisting, $50 million Q4 revenue, closure of SEC investigation and independent board....and none of it happened.

As a matter of fact, Musclepharm just diluted the stock with 5 million shares at all time lows, with 1.5 million shares protecting executives' control, votes and ownership (special rights that as a rule are reserved for existing shareholders).

Revenues dropped sharply in second half of last year, so even with $75 million in Q1 revenue, Brad and the Board have lost all credibility imo.

Fact is that the stock has gone from $14 to $4, and that the top management and the board have no chance of ever earning the trust and respect of professional investors.

MSLP will remain to be a lottery ticket for daytraders to pump and dump, but never provide any guarantee of return for long term investors.

[drive929]

Where did you find this?